Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in RNAZ — Transcode Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in RNAZ

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$109,690
+$40,161 QoQ
Shares Held
12,740
+9551.5% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in RNAZ

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $109,690 12,740
2024-09-30 $69,529 121,768
2024-06-30 $38,589 38,398
2023-12-31 $8,618 52,232
2023-03-31 75,683
2022-12-31 $51,517 76,549
2022-09-30 76,549
2022-06-30 76,549
2022-03-31 71,272
2021-12-31 71,272
2021-09-30 17,023